Privium Fund Management B.V. Zai Lab LTD Transaction History
Privium Fund Management B.V.
- $354 Million
- Q2 2024
A detailed history of Privium Fund Management B.V. transactions in Zai Lab LTD stock. As of the latest transaction made, Privium Fund Management B.V. holds 215,789 shares of ZLAB stock, worth $6.78 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
215,789
Previous 240,683
10.34%
Holding current value
$6.78 Million
Previous $3.86 Million
3.01%
% of portfolio
1.06%
Previous 1.14%
Shares
5 transactions
Others Institutions Holding ZLAB
# of Institutions
116Shares Held
40.8MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$224 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$205 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$167 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$73.3 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$64 Million0.14% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.08B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...